VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
ResMed Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ResMed Inc.
RMD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Sanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: ResMed Inc. leads (76 / 100 vs 74 / 100 for Sanofi).
- Segment focus: ResMed Inc. has 2 segments (87.5% in Sleep and Breathing Health); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: ResMed Inc. has 7 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
ResMed Inc.
Sleep and Breathing Health
Sleep apnea and respiratory care devices and related consumables (PAP, masks, ventilation) plus connected monitoring services
Global
DME/HME providers, sleep clinics, hospitals, patients
Medical device OEM + connected care software/data services
87.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
ResMed Inc. strengths
Sanofi strengths
Segment mix
ResMed Inc. segments
Full profile >Sleep and Breathing Health
Oligopoly
Residential Care Software
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.